The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

Clinical trial NCT06606821 · RECRUITING

Trial details

NCT number: NCT06606821
Sponsor: Tina Vilsbøll
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease Coronary Microvascular Dysfunction Overweight or Obesity Stable Angina Pectoris Chronic Coronary Artery Disease Atherosclerosis Cardiovascular Disease

Start date: 2024-10-01
Primary completion: 2027-03-20
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.